Press release
Change in the Biohit Oyj Management Team
Publishing on March 11, 2026 at 1:00 pm local time (EET)
Biohit Oyj has appointed Ville Suovaniemi as Head of Global Sales & Marketing and a member of the Management Group.
Ville Suovaniemi, who has worked at Biohit since 2017, has extensive experience in the company’s sales functions as well as a comprehensive understanding of its products and international markets.
The responsibilities have previously been covered by Graham Johnson alongside his role as Managing Director of Biohit Healthcare Ltd, UK. As the outlook for Biohit’s business in the UK market is currently very promising, the company will increase its management focus and resources in the market to support the realization of the growing commercial potential.
Graham Johnson will remain a member of the Biohit Management Group in addition to his role as subsidiary Managing Director.
The changes reflect Biohit’s strategy to allocate management resources to support the company’s growth and to ensure readiness to meet increasing demand in its key markets.
The changes will take effect immediately.
Additional information:
Jussi Hahtela, CEO, Biohit Oyj, tel. +358 50 383 5948
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.